Rivastigmine 00781-7313
Product NDC
00781-7313- Manufacturer
- Sandoz Inc
- Dosage Form
- Patch, Extended Release
- Route
- Transdermal
- Product Type
- Human Prescription Drug
- Marketing Start
- September 2, 2015
- Listing Expires
- December 31, 2026
- Application
- NDA022083
Need to source Rivastigmine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Rivastigmine | 13.3 mg/24h |
Drug Class
Cholinesterase Inhibitor [EPC]Cholinesterase Inhibitor [EPC]Cholinesterase Inhibitors [MoA]
Packaging Options(1)
30 PATCH in 1 CARTON (0781-7313-31) / 24 h in 1 PATCH (0781-7313-58)